Qingdao Saber Technology Pharma QST
Retatrutide
Finnrick tested 8 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Qingdao Saber Technology Pharma QST between 3 Jun 2025 and 23 Apr 2026. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).
Finnrick Rating™
Qingdao Saber Technology Pharma QST
Retatrutide
Tested 8 Samples
Last test 23 Apr 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Qingdao Saber Technology Pharma QST
Samples are tested in commercial labs
Tests Count
8
Scores
AVGMINMAX
Last
23 Apr 2026
First
3 Jun 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 23 Apr 2026 | View | 5mg | 5.11mg | +2.2% | 99.90% | R525La01 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 29 Dec 2025 | View | 20mg | 22mg | +10.0% | 99.60% | R2025Ja01 | No Label / Silver Crimp / Violet Cap | Lab G | Public | |
| 11 Dec 2025 | View | 10mg | 10.4mg | +4.0% | 99.92% | R1025Ja01 | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 1 Sep 2025 | View | 5mg | 5.68mg | +13.6% | 99.45% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab F | Public | |
| 4 Aug 2025 | View | 10mg | 9.89mg | -1.1% | 98.52% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 17 Jul 2025 | View | 10mg | 8.46mg | -15.4% | 99.94% | (no batch ID) | White Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 9 Jun 2025 | View | 20mg | 24.9mg | +24.5% | 99.85% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 3 Jun 2025 | View | 20mg | 20.2mg | +1.0% | 99.62% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |